vs
Side-by-side financial comparison of Commerce.com, Inc. (CMRC) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $89.5M, roughly 1.8× Commerce.com, Inc.). Commerce.com, Inc. runs the higher net margin — -9.3% vs -82.0%, a 72.6% gap on every dollar of revenue. On growth, Commerce.com, Inc. posted the faster year-over-year revenue change (2.9% vs -22.7%). Commerce.com, Inc. produced more free cash flow last quarter ($-2.2M vs $-36.6M). Over the past eight quarters, Commerce.com, Inc.'s revenue compounded faster (5.5% CAGR vs -11.5%).
SPS Commerce, Inc. is a technology and application software company based in the United States that provides cloud-based supply chain management software. The company's headquarters are located in Minneapolis, Minnesota, but it also has a US office in New Jersey, and international locations in Amsterdam, Beijing, Breukelen, Hong Kong, Kyiv, Melbourne, Montpellier, Sydney, and Toronto.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
CMRC vs PTCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $89.5M | $164.7M |
| Net Profit | $-8.4M | $-135.0M |
| Gross Margin | 78.3% | — |
| Operating Margin | -7.4% | -43.3% |
| Net Margin | -9.3% | -82.0% |
| Revenue YoY | 2.9% | -22.7% |
| Net Profit YoY | -250.0% | -104.8% |
| EPS (diluted) | $-0.11 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $89.5M | $164.7M | ||
| Q3 25 | $86.0M | $211.0M | ||
| Q2 25 | $84.4M | $178.9M | ||
| Q1 25 | $82.4M | $1.2B | ||
| Q4 24 | $87.0M | $213.2M | ||
| Q3 24 | $83.7M | $196.8M | ||
| Q2 24 | $81.8M | $186.7M | ||
| Q1 24 | $80.4M | $210.1M |
| Q4 25 | $-8.4M | $-135.0M | ||
| Q3 25 | $-2.2M | $15.9M | ||
| Q2 25 | $-8.4M | $-64.8M | ||
| Q1 25 | $-353.0K | $866.6M | ||
| Q4 24 | $-2.4M | $-65.9M | ||
| Q3 24 | $-7.0M | $-106.7M | ||
| Q2 24 | $-11.3M | $-99.2M | ||
| Q1 24 | $-6.4M | $-91.6M |
| Q4 25 | 78.3% | — | ||
| Q3 25 | 78.4% | — | ||
| Q2 25 | 79.0% | — | ||
| Q1 25 | 79.4% | — | ||
| Q4 24 | 77.6% | — | ||
| Q3 24 | 76.3% | — | ||
| Q2 24 | 75.8% | — | ||
| Q1 24 | 77.1% | — |
| Q4 25 | -7.4% | -43.3% | ||
| Q3 25 | -0.5% | 1.4% | ||
| Q2 25 | -8.0% | -19.5% | ||
| Q1 25 | -2.9% | 82.5% | ||
| Q4 24 | -0.9% | -76.2% | ||
| Q3 24 | -23.0% | -27.7% | ||
| Q2 24 | -16.5% | -21.5% | ||
| Q1 24 | -10.2% | -21.6% |
| Q4 25 | -9.3% | -82.0% | ||
| Q3 25 | -2.6% | 7.5% | ||
| Q2 25 | -9.9% | -36.3% | ||
| Q1 25 | -0.4% | 73.7% | ||
| Q4 24 | -2.7% | -30.9% | ||
| Q3 24 | -8.4% | -54.2% | ||
| Q2 24 | -13.8% | -53.1% | ||
| Q1 24 | -8.0% | -43.6% |
| Q4 25 | $-0.11 | $-1.63 | ||
| Q3 25 | $-0.03 | $0.20 | ||
| Q2 25 | $-0.10 | $-0.83 | ||
| Q1 25 | $0.00 | $10.04 | ||
| Q4 24 | $-0.03 | $-0.85 | ||
| Q3 24 | $-0.09 | $-1.39 | ||
| Q2 24 | $-0.15 | $-1.29 | ||
| Q1 24 | $-0.08 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $141.1M | $1.9B |
| Total DebtLower is stronger | $157.0M | — |
| Stockholders' EquityBook value | $39.4M | $-205.3M |
| Total Assets | $308.8M | $2.9B |
| Debt / EquityLower = less leverage | 3.99× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $141.1M | $1.9B | ||
| Q3 25 | $142.0M | $1.7B | ||
| Q2 25 | $134.5M | $2.0B | ||
| Q1 25 | $120.7M | $2.0B | ||
| Q4 24 | $178.2M | $1.1B | ||
| Q3 24 | $168.4M | $1.0B | ||
| Q2 24 | $275.8M | $1.1B | ||
| Q1 24 | $265.2M | $884.8M |
| Q4 25 | $157.0M | — | ||
| Q3 25 | $157.3M | — | ||
| Q2 25 | $157.5M | — | ||
| Q1 25 | $157.8M | — | ||
| Q4 24 | $216.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $340.9M | — | ||
| Q1 24 | $340.5M | — |
| Q4 25 | $39.4M | $-205.3M | ||
| Q3 25 | $42.8M | $-155.8M | ||
| Q2 25 | $38.8M | $-206.5M | ||
| Q1 25 | $38.1M | $-185.8M | ||
| Q4 24 | $33.4M | $-1.1B | ||
| Q3 24 | $29.0M | $-1.1B | ||
| Q2 24 | $26.1M | $-980.2M | ||
| Q1 24 | $26.9M | $-893.9M |
| Q4 25 | $308.8M | $2.9B | ||
| Q3 25 | $309.5M | $2.6B | ||
| Q2 25 | $302.5M | $2.6B | ||
| Q1 25 | $286.3M | $2.7B | ||
| Q4 24 | $340.3M | $1.7B | ||
| Q3 24 | $335.1M | $1.8B | ||
| Q2 24 | $452.5M | $1.9B | ||
| Q1 24 | $442.5M | $1.8B |
| Q4 25 | 3.99× | — | ||
| Q3 25 | 3.67× | — | ||
| Q2 25 | 4.06× | — | ||
| Q1 25 | 4.14× | — | ||
| Q4 24 | 6.49× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 13.06× | — | ||
| Q1 24 | 12.65× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $980.0K | $-34.3M |
| Free Cash FlowOCF − Capex | $-2.2M | $-36.6M |
| FCF MarginFCF / Revenue | -2.4% | -22.3% |
| Capex IntensityCapex / Revenue | 3.5% | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $16.9M | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $980.0K | $-34.3M | ||
| Q3 25 | $10.6M | $-66.3M | ||
| Q2 25 | $13.6M | $-58.3M | ||
| Q1 25 | $401.0K | $870.1M | ||
| Q4 24 | $12.4M | $-30.0M | ||
| Q3 24 | $5.6M | $-77.0M | ||
| Q2 24 | $11.7M | $-71.5M | ||
| Q1 24 | $-3.4M | $70.8M |
| Q4 25 | $-2.2M | $-36.6M | ||
| Q3 25 | $7.6M | $-69.7M | ||
| Q2 25 | $11.9M | $-59.6M | ||
| Q1 25 | $-424.0K | $868.4M | ||
| Q4 24 | $11.6M | $-33.8M | ||
| Q3 24 | $4.5M | $-77.5M | ||
| Q2 24 | $10.7M | $-78.8M | ||
| Q1 24 | $-4.2M | $61.2M |
| Q4 25 | -2.4% | -22.3% | ||
| Q3 25 | 8.8% | -33.1% | ||
| Q2 25 | 14.1% | -33.3% | ||
| Q1 25 | -0.5% | 73.8% | ||
| Q4 24 | 13.3% | -15.8% | ||
| Q3 24 | 5.4% | -39.4% | ||
| Q2 24 | 13.0% | -42.2% | ||
| Q1 24 | -5.3% | 29.1% |
| Q4 25 | 3.5% | 1.4% | ||
| Q3 25 | 3.4% | 1.6% | ||
| Q2 25 | 2.0% | 0.7% | ||
| Q1 25 | 1.0% | 0.1% | ||
| Q4 24 | 0.9% | 1.8% | ||
| Q3 24 | 1.3% | 0.3% | ||
| Q2 24 | 1.3% | 4.0% | ||
| Q1 24 | 1.0% | 4.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | -4.17× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.00× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CMRC
| Subscription And Circulation | $65.2M | 73% |
| Partner And Services | $24.4M | 27% |
PTCT
Segment breakdown not available.
